← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Signum Biosciences
Monmouth Junction, NJ
$10,546,237
Total funding
7
Grants
Funding over time
peak $2M · FY2008–19$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$10,546,237 · 7
By mechanism
R44$9,238,679 · 3
R43$1,307,558 · 4
Investigators at Signum Biosciences
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis$1,136,065
R44 · FY2018 · AI
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis$1,050,155
R44 · FY2017 · AI
A Topical Non Steroidal Anti-inflammatory for Rosacea$1,007,031
R44 · FY2011 · AI
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis$998,971
R44 · FY2013 · AR
A Topical Non Steroidal Anti-inflammatory for Rosacea$990,578
R44 · FY2012 · AI
A Topical Non Steroidal Anti-inflammatory for Rosacea$978,283
R44 · FY2013 · AI
Topical Non-Steroidal Anti-Inflammatories for the Treatment of Rosacea$838,194
R44 · FY2010 · AI
Topical Non-Steroidal Anti-Inflammatories for the Treatment of Rosacea$785,099
R44 · FY2009 · AI
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis$778,244
R44 · FY2019 · AI
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis$676,059
R44 · FY2014 · AR
A Novel Class of Therapeutic Agents for the Treatment of Skin Diseases Associated$356,919
R43 · FY2010 · AR
A Novel Class of Topical Pleitropic Anti-Acne Therapeutics$327,178
R43 · FY2010 · AR
Phosphoprotein phosphatase 2A, a new target for Alzheimer's Disease interventio$324,717
R43 · FY2010 · AG
A Novel Class of Non Steroidal Anti-Inflammatories$298,744
R43 · FY2008 · AI